Results 201 to 210 of about 90,622 (332)

From Trials to Practice: A 2025 Review of Idecabtagene Vicleucel and Ciltacabtagene Autoleucel Efficacy Across Clinical Studies and Real‐World Evidence

European Journal of Haematology, EarlyView.
ABSTRACT B‐cell maturation antigen (BCMA)‐directed chimeric antigen receptor (CAR) T‐cell therapies have revolutionized the approach and management of relapsed/refractory multiple myeloma (RRMM), and as of 2025, idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) are the only BCMA‐targeted CAR T‐cell therapies approved by the FDA.
Hector Garcia Pleitez, Sakditad Saowapa, Andrea Ortiz Maldonado, Chanakarn Kanitthamniyom, Diego Olavarria Bernal, Lukman Tijani   +5 more
wiley   +1 more source

Extracorporeal photopheresis therapy rapidly changes the cytokine profile and tumor microenvironment in cutaneous T cell lymphoma. [PDF]

Front Immunol
Melchers S, Tengler L, Şener ÖÇ, Beltzig PL, Schmidt R, Klein S, Utikal JS, Nicolay JP.   +7 more
europepmc   +1 more source

Epidermal Interferon-γ Inducible Protein-10 (IP-10) and Monokine Induced by γ-Interferon (Mig) but not IL-8 mRNA Expression is Associated with Epidermotropism in Cutaneous T Cell Lymphomas

, 1998
Cornelis P. Tensen, Maarten H. Vermeer, Petra M. van der Stoop, Peter van Beek, Rik J. Scheper, D. M. Boorsma, Rein Willemze   +6 more
openalex   +1 more source

CD4+ cutaneous T-cell lymphoma cells express the p140–killer cell immunoglobulin-like receptor [PDF]

, 2001
M. Bagot, Alessandro Moretta, Simona Sivori, Roberto Biassoni, Claudia Cantoni, Cristina Bottino, Laurence Boumsell, Armand Bensussan   +7 more
openalex   +1 more source

Diffuse plane xanthomas as the first manifestation of multiple myeloma

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Eleni Koutra, Elke Lusmöller, Hosam Ghanem, Astrid Aumann, Jens Atzpodien, Rudolf Stadler   +5 more
wiley   +1 more source

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

European Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

Serological detection of cutaneous T-cell lymphoma-associated antigens [PDF]

, 2001
Stefan B. Eichmüller, Dirk Usener, Reinhard Dummer, Angelika Stein, Daniela Thiel, Dirk Schadendorf   +5 more
openalex   +2 more sources

First report of indolent cutaneous T-cell lymphoma in a fennec fox (Vulpes zerda). [PDF]

Vet Dermatol
Shekelle KL, Glassman AR, Backues KA, Kilburn JJ, Foust-Wheatcraft DA, Stranahan LW.   +5 more
europepmc   +1 more source

Skewed Expression of Activation, Differentiation and Homing-Related Antigens in Circulating Cells from Patients with Cutaneous T Cell Lymphoma Associated with CD7– T Helper Lymphocytes Expansion

, 1999
Enrico Scala, S. Cadoni, Carlo Renè Girardelli, Ornella De Pità, Pietro Puddu, Giandomenico Russo, Maria Grazia Narducci   +6 more
openalex   +1 more source

Ulcerated nodules in a sporotrichoid distribution. [PDF]

, 2019
de Feraudy, Sebastien, Elsensohn, Ashley N, Hosking, Anna-Marie, Kraus, Christina N, Shiu, Jessica, Smith, Janellen   +5 more
core